Anti-MRSA agents: under investigation, in the exploratory phase and clinically available (Q36233502)

12 August 2017

1 reference

title

Anti-MRSA agents: under investigation, in the exploratory phase and clinically available (English)

1 reference

12 August 2017

André Bryskier

1

1 reference

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Expert Review of Anti-infective Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

3

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

505-553

1 reference

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

“Celbenin” - resistant Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Oxazolidinone antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Vancomycin disulfide derivatives as antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

In vitro activities of LY333328 and comparative agents against nosocomial gram-positive pathogens collected in a 1997 global surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Semi-synthetic glycopeptide antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

In vitro activity of TD-6424 against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Anti-MRSA activity of alkyl gallates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

A series of spirocyclic analogues as potent inhibitors of bacterial phenylalanyl-tRNA synthetases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-positive antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Conformational restriction of methionyl tRNA synthetase inhibitors leading to analogues with potent inhibition and excellent gram-positive antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Antibacterial properties of a new isoflavonoid from Erythrina poeppigiana against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Prodrugs of cephalosporin RWJ-333441 (MC-04,546) with improved aqueous solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Improvement of water-soluble cephalosporin derivatives having antibacterial activity against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Dicationic dithiocarbamate carbapenems with anti-MRSA activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Antibiotic Substances From Basidiomycetes: VIII. Pleurotus Multilus (Fr.) Sacc. and Pleurotus Passeckerianus Pilat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

In vitro activity of the new quinolone WCK 771 against staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

The synthesis and antibacterial activity of 1,3,4-Thiadiazole phenyl oxazolidinone analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

New Antibacterial tetrahydro-4(2H)-thiopyran and thiomorpholine S-oxide and S,S-dioxide phenyloxazolidinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.505

TPU-0037-A, B, C and D, Novel Lydicamycin Congeners with Anti-MRSA Activity from Streptomyces platensis TP-A0598.

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.55.873

TPU-0031-A and B, new antibiotics of the novobiocin group produced by Streptomyces sp. TP-A0556

12 April 2024

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.54.441

Tripropeptins, novel antimicrobial agents produced by Lysobacter sp. I. Taxonomy, isolation and biological activities

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.54.1054

Sch 40832: a novel thiostrepton from Micromonospora carbonacea

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.51.221

Diperamycin, a New Antimicrobial Antibiotic Produced by Streptomyces griseoaurantiacus MK393-AF2. I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.51.1087

TAN-1057 A-D, new antibiotics with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Taxonomy, fermentation and biological activity.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.606

Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.45.832

Lydicamycin, a new antibiotic of a novel skeletal type. II. Physico-chemical properties and structure elucidation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.44.288

Lydicamycin, a new antibiotic of a novel skeletal type. I. Taxonomy, fermentation, isolation and biological activity.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.44.282

New glycopeptide antibiotics: II. The isolation and structures of chloroorienticins

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1506

A new anti-MRSA antibiotic complex, WAP-8294A. I. Taxonomy, isolation and biological activities.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.51.929

Nematophin, a novel antimicrobial substance produced by Xenorhabdus nematophilus (Enterobactereaceae)

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1139/M97-110

Identifiers

DOI

10.1586/14787210.3.4.505

1 reference

12 August 2017

1 reference